Gritstone Oncology

Gritstone's goal is to develop groundbreaking immunotherapies for cancers and infectious diseases. Our approach focuses on generating a therapeutic immune ...

Gritstone files for bankruptcy in hope of keeping R&D afloat

Gritstone Oncology bankruptcy Biotech graveyard cancer vaccine. Share. Bankruptcy Gritstone bio is already in discussions with a potential ...

Cash-strapped Gritstone starts search for strategic alternatives as ...

Gritstone Oncology clinical trial data colorectal cancer cancer vaccine. Share. money, time The biotech's ability to keep going is in doubt ...

Gritstone Oncology Pursues Restructuring Through Chapter 11

Gritstone Oncology ( (GRTS) ) has shared an update. Gritstone bio, Inc., a biotech firm specializing in potent vaccines, has voluntarily ...

Gilead Sciences and Gritstone Announce Collaboration Utilizing ...

Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types ...

Gritstone bio Takes Action to Preserve Value and Strengthen Capital ...

Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the ... oncology and medical breakthroughs. We recently reported encouraging ...

bluebird bio and Gritstone Oncology Announce Strategic ...

bluebird bio, Inc. (Nasdaq: BLUE) and Gritstone Oncology, Inc. today announced a collaboration to research, develop and commercialize products for the ...

Gritstone Oncology | Seqera

Gritstone manages targeted immunotherapies for cancer and infectious disease.

Gritstone Oncology, Inc. - AnnualReports.com

Gritstone Oncology, Inc. ... Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer ...

Gritstone Oncology and Arbutus Biopharma Announce LNP ...

Gritstone Oncology and Arbutus Biopharma Announce LNP Technology Licensing Agreement to Develop Novel RNA-Based Personalized Neoantigen Immunotherapies for ...

Gritstone Oncology - BioSpace

Gritstone bio - Wikipedia

It was founded in August 2015 as Gritstone Oncology, Inc., and is based in Emeryville, California. In September 2021 it raised $55.0 million from the sale ...

Gritstone bio (@gritstonebio) / X

Gritstone bio is a clinical-stage biotechnology company that ... 2 at 9 a.m. ET join us for a virtual KOL event w/ UCLA GI Oncology Program Professor J.

Gritstone bio - LinkedIn

With our unique approach to immuno-oncology and infectious diseases, we seek to generate a therapeutic immune response by leveraging insights into the immune ...

Gritstone bio - Crunchbase Company Profile & Funding

Also Known As Gritstone Oncology, Gritstone Oncology, Inc. Legal Name Gritstone bio, Inc. ... immunity. With the development and commercialization of ...

S-1 - SEC.gov

This is an initial public offering of shares of common stock of Gritstone Oncology, Inc. We are offering shares of our common stock.

Gritstone Oncology Inc. - Emeryville, USA - Bionity

Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. Gritstone's approach seeks to generate a therapeutic ...

Gritstone Bio says personalized cancer vaccine falls short in key trial

To measure whether the vaccine was eliminating cancer cells, Gritstone decided to look at levels of circulating tumor DNA, or ctDNA — genomic ...

Gritstone Oncology Changes its Name to Gritstone bio to

GRTS_2021_logoupdate_color.jpg · Gritstone Oncology Changes its Name to Gritstone bio to Reflect Expanded Therapeutic Focus. May 03, 2021 08:00 ...

First participant enrolled in Gritstone second generation COVID-19 ...

Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types ...